Navigation Links
Hill-Rom Reports Second Quarter Financial Results
Date:5/4/2009

- Revenue of $337 million declined 10.1 percent versus prior year primarily due to economic impact on U.S. hospital capital spending and foreign exchange

- Adjusted earnings per fully diluted share from continuing operations was $0.27 versus $0.26 in prior year, an increase of 3.8 percent

- GAAP loss per fully diluted share from continuing operations of $7.44 resulted from estimated $470 million non-cash intangible impairment charge related to market value decline

- Adjusted operating expenses exclusive of Liko declined $19.8 million (14.2 percent) on initiatives to reduce cost structure

- Liko performance and integration progressing as expected

- Cash flow and liquidity improved versus prior year and sequentially

- Management updates adjusted annual financial guidance for fiscal year 2009 to $0.85 to $1.15 per fully diluted share

BATESVILLE, Ind., May 4 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), announced unaudited financial results for its fiscal second quarter ended March 31, 2009. Revenue was $337.3 million, a 10.1 percent decrease from $375.2 million in the prior year comparable period. On a constant currency basis, revenue decreased 5.7 percent. Organic revenue (excludes currency impact and Liko revenue of $18.0 million) decreased 10.5 percent. Hill-Rom incurred a net loss from continuing operations of $465.8 million, or $7.44 per fully diluted share, on an impairment of goodwill and other intangibles of $470 million. Adjusted earnings per fully diluted share from continuing operations were $0.27, an increase of 3.8 percent from the prior year. Adjustments in the current period include the impairment of intangibles, effects of severance and related expenses associated with job eliminations and other actions announced in January 2009, lower Liko margins associated with the valuation of acquired inventories and Liko integration costs. Adjustments in the prior year include costs associated with the spin-off of the funeral services business, primarily a stock modification charge and a loss on the extinguishment of debt. Unless otherwise indicated, amounts in the current quarter include the results of Liko, acquired on October 1, 2008.

Management Comments

"Consistent with our previous outlook, U.S. hospital and extended care customers continued to take a very cautious view toward capital spending as a result of recessionary concerns, yet our International and Post Acute businesses held steady. Our sales results also suggest that Hill-Rom is faring about the same as other capital equipment-intensive medical technology companies," commented Peter H. Soderberg, president and CEO of Hill-Rom. "In spite of the current softness in U.S. hospital capital equipment demand, we are maintaining our on-going multi-year growth strategy, while accelerating our efforts to reduce costs in both supply chain and other expense areas. We are pleased with the first six months of performance by our new Liko unit, and continue to integrate this business into our global and cross-continuum businesses as anticipated. We believe these efforts will position the company for future growth in anticipation of a return to more normalized customer demand."

Soderberg continued, "As a result of our manufacturing, service, and operating expense cost control initiatives, gross profit and operating profit margins, as adjusted, expanded both sequentially and year-over-year. We limited the decline in adjusted operating income to 2.2 percent, while only slightly reducing our investments in selling and R&D. While we cannot predict the timing of when hospitals and other providers will return to more normalized capital acquisition behavior, we should be well positioned to resume our predicted long term growth rates in sales and profitability once the underlying fundamentals of demand for our products are restored. In the meantime, we will continue to focus on actions to improve our cost structure and increase our customer value proposition."

As a result of the decline in our market capitalization as measured on March 31, 2009 related to the overall macro-economic climate and the impact on hospital capital spending, GAAP accounting and SEC requirements obligated us to conduct goodwill impairment testing. The test resulted in the company recording an estimated non-cash charge of $470 million in the quarter. The amount of the charge is subject to finalization in the third quarter. As this impairment charge is non-cash in nature, it does not affect liquidity, debt covenants or cash flow from operations. Further, this charge does not impact the company's outlook for future growth or its business plan.

Soderberg concluded, "In spite of unprecedented pressures on the enterprise, Hill-Rom's financial position remains strong. We are diversifying our business, and delivering growth at or above market in most of our units. Our balance sheet is healthy, cash flow increased both sequentially and year-over-year and the cadence of new product introduction continues to improve."

Other second quarter revenue highlights regarding Hill-Rom business segments include:

-- North America Acute Care. Revenue declined $42.3 million, or 18.3 percent, to $188.6 million. Capital sales decreased 25.6 percent (23.5 percent constant currency), primarily driven by decreases in our patient support systems and furniture products, offset by gains in our healthcare information technology unit. Rental revenue was essentially flat during the quarter. While capital spending at U.S. hospitals has been significantly impacted by economic pressures, rental revenue held flat primarily due to the popularity of our Envision(R) E-700 wound surface and TotalCare(R) Bariatric Plus products. This favorability was offset by the absence of a more typical flu and pneumonia season versus the unusually intense season of the prior year.

-- International and Surgical. Revenue increased $3.8 million, or 3.9 percent, to $100.8 million, principally driven by the acquisition of Liko and strong growth outside of Europe. Constant currency growth was 16.5 percent. European revenues slowed during the quarter, decreasing low-single digits organically. Revenues in the rest of the world increased in excess of 40 percent. Allen Medical continued to grow at high single digit rates, indicating that the demand for surgical capital equipment remains reasonably strong.

-- North America Post-Acute Care. Revenue increased $0.9 million, or 1.9 percent, to $48.9 million. Capital sales increased by $2.7 million, or 31.8 percent, primarily due to the Liko acquisition, sales channel initiatives and direct to consumer sales. Rental revenue declined by $1.8 million, or 4.6 percent, with strong respiratory care performance offset by weaker home care and extended care revenues. Our extended care business was impacted by prior year contract losses, the effects of the economy on capital sales and a weak flu season compared to last year.

Other Second Quarter Financial and Operational Highlights

-- Gross profit declined $13.9 million to $153.4 million, primarily related to reduced capital volume; however, gross margin increased by 90 basis points to 45.5 percent due to the strength of rental margins, manufacturing cost savings initiatives and other job elimination actions announced in August and January. Capital gross profit declined by 17.7 percent, and gross margin was down 180 basis points versus the prior year primarily due to the reduced volume and unfavorable product mix. Rental gross profit grew by 7.5 percent and associated gross margin improved 490 basis points, due primarily to new product introductions and lower field service costs.

-- Operating expenses declined by $18.8 million, or 12.8 percent. As a percent of sales, operating expenses declined 120 basis points to 38.0 percent. Job elimination actions, volume-related compensation savings, prior year funeral services spin-off-related costs and other general and administrative cost savings actions were the primary drivers of these lower expense levels. Liko operating expenses for the quarter totaled $8.3 million, bringing the total reduction in operating expenses on an as adjusted basis to 14.2 percent, excluding Liko.

-- Hill-Rom cash flow from operations was $55.1 million, an increase of 6.8 percent. Free cash flow was $39.1 million, an increase of 70.7 percent. The company's cash position improved to $84.6 million, up $35.1 million from last quarter.

-- The income tax rate for the quarter is unusual in light of the significance of the non-cash intangible charge and the lack of deductibility of this charge for income tax purposes. On an as adjusted basis, the effective tax rate was 35.2 percent for the quarter compared to 40.9 percent in the prior year. Discrete tax expense was recognized in each period in the amounts of $0.8 million and $1.8 million, respectively.

-- During the quarter we announced a plan to aggressively manage our cost structure through: Consolidation of certain manufacturing and selected back office operations; redeployment of U.S. sales and service resources to increase our customer presence and support; reduction in non-sales, non-research and development expenses; a voluntary early retirement program, and involuntary job eliminations. We also wrote-off certain operating assets associated with these initiatives. In conjunction with these actions we recognized a special charge of nearly $18 million. Some additional costs associated with these actions are also expected to be incurred in the third quarter, but such are not expected to exceed $2.0 million. The expected annual savings from these actions are estimated to be $12 to $14 million.

-- During the quarter, the company successfully resolved an outstanding Food and Drug Administration (FDA) Warning Letter.

On March 31, 2008, Hill-Rom completed the spin-off of its funeral services business operating under the Batesville Casket name. Accordingly, the results of operations of the funeral services business, including certain separation related costs and other income and expenses assigned to the funeral services business, have been presented as discontinued operations for all periods presented in the Condensed Consolidated Statements of Income.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted accounting principles ("GAAP") to as adjusted income and earnings per share, condensed financial information, summary balance sheet information and segment sales summaries.

For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, which will be filed later this week.

Financial Guidance Summary For 2009

Management is updating full year 2009 adjusted financial guidance. Soderberg stated, "In spite of unprecedented economic turmoil affecting customer demand, we are in a position to update our guidance because of year to date performance and expense management actions that have improved cash flow and profitability versus our earlier outlook."

Hill-Rom's consolidated revenue guidance range for fiscal 2009 is expected to be $1.365 to $1.423 billion, which represents a 5.6 to 9.5 percent reduction versus prior year. The prior revenue guidance range was $1.375 to $1.470 billion. Our GAAP loss per fully diluted share from continuing operations is expected to be in the range of $6.61 to $6.91, versus a prior earnings range of $0.66 to $1.05. Adjusted earnings per fully diluted share are now expected to be $0.85 to $1.15. The prior guidance range was $0.82 to $1.18. Financial guidance in tabular format is included in the attached schedule.

Hill-Rom Holdings, Inc. provides earnings per share guidance on an adjusted basis from continuing operations because the company's management believes that the presentation provides useful information to investors. This measure excludes strategic developments, special charges, the impact of significant litigation and impairment charges. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the company's reported operations for a period. Often, quantification of such items is not feasible. Management uses these measures internally for planning, forecasting and evaluating the performance of the business, including evaluating results relative to employee performance compensation targets. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Conference Call Replay and Webcast

The company will sponsor a conference call and webcast for the investing public at 8 a.m. EDT, 7 a.m. CDT, on Tuesday, May 5, 2009. The webcast is available at http://ir.hill-rom.com/events.cfm or http://ir.hill-rom.com/eventdetail.cfm?eventid=67432 and will be archived on the company's website through May 4, 2010 for those who are unable to listen to the live webcast. A replay of the call is also available through May 12, 2009 at 888-203-1112 (719-457-0820 International). Code 4029133 is needed to access the replay.

About Hill-Rom Holdings, Inc.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "should," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential," "maintain," "fare" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the recent spin-off of the funeral service business, failure to realize the anticipated benefits of the spin-off, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2008 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, which will be filed later this week. The Company assumes no obligation to update or revise any forward-looking statements.

                             Hill-Rom Holdings, Inc.
                         Condensed Financial Information
                                    Unaudited
                   (Dollars in millions except per share data)


     Condensed Statement of
      Earnings                     2Q09     1Q09     4Q08     3Q08     2Q08
    -----------------------       ------   ------   ------   ------   ------
    Net revenues
      Capital sales               $219.6   $236.0   $309.3   $249.9   $255.3
      Rental revenues              117.7    115.6    115.0    116.9    119.9
                                   -----    -----    -----    -----    -----
        Total revenues             337.3    351.6    424.3    366.8    375.2
    Cost of revenues
      Cost of goods sold           133.2    146.5    181.3    150.5    150.3
      Rental expenses               50.7     52.6     53.4     55.7     57.6
                                    ----     ----     ----     ----     ----
        Total cost of revenues     183.9    199.1    234.7    206.2    207.9
    Gross profit
      Capital sales                 86.4     89.5    128.0     99.4    105.0
      Rental revenues               67.0     63.0     61.6     61.2     62.3
                                    ----     ----     ----     ----     ----
        Total gross profit         153.4    152.5    189.6    160.6    167.3
      As a percentage of sales      45.5%    43.4%    44.7%    43.8%    44.6%

    Operating expense              128.1    129.5    133.4    137.3    146.9
      As a percentage of sales      38.0%    36.8%    31.4%    37.4%    39.2%

    Impairment of goodwill and
     other intangibles            (470.0)       -        -        -        -
    Special charges                (17.8)       -    (20.5)       -        -
                                   -----    -----    -----    -----    -----

    Operating (loss) profit       (462.5)    23.0     35.7     23.3     20.4

    Other income/(expense), net     (1.5)    (2.0)    (2.9)    (1.3)    (3.5)

    Income tax expense (1)           1.8      6.8      9.0      0.5      7.5

                                 -------    -----    -----    -----     ----
    (Loss) Income from
     continuing operations       $(465.8)   $14.2    $23.8    $21.5     $9.4
                                 -------    -----    -----    -----     ----

    Diluted (loss) earnings
     per share:
      (Loss) Earnings per share
       from continuing
       operations                 $(7.44)   $0.23    $0.38    $0.34    $0.15

    Average common shares
     outstanding  - diluted
     (thousands)                  62,578   62,808   62,734   62,655   62,566

    Dividends per common share   $0.1025  $0.1025  $0.1025  $0.1025  $0.2850

    Consolidated Cash Flows
     from Operations (2)
      Cash flow from operations    $55.1    $34.9    $43.3    $23.0    $84.1
      Less: capital expenditures   (16.0)   (13.6)   (25.3)   (20.6)   (30.7)
                                   -----    -----    -----    -----    -----
      Consolidated free cash flow  $39.1    $21.3    $18.0     $2.4    $53.4
                                   -----    -----    -----     ----    -----

      Cash and cash equivalents    $84.6    $49.5   $221.7   $131.2   $145.9
      Investments and
       investment securities (3)   $44.8    $43.0    $45.6    $47.0    $49.4

    Hill-Rom Capital Expenditures  $16.0    $13.6    $25.3    $20.6    $28.7
    Hill-Rom Depreciation &
     Amortization                  $24.8    $26.1    $28.1    $25.5    $25.5



    (1) For fiscal year 2008, discrete tax benefits totaled $8.3 million
        ($0.13 per share), $7.8 million ($0.12 per share) of which was
        recognized in the third fiscal quarter, principally associated with
        the release of valuation allowances on foreign tax credit
        carryforwards and the recognition of certain previously unrecognized
        tax benefits associated with recently completed tax audits.  For the
        three- and six-month periods ended March 31, 2009, we recognized
        discrete tax expense of $0.8 million and discrete tax benefits of $0.5
        million, respectively, compared to discrete tax expense of $1.8
        million and $1.1 million in the prior period comparable periods.

    (2) Consolidated cash flow amounts are "as reported" and thus include cash
        flows from the funeral services business through March 31, 2008.

    (3) Beginning June 30, 2008, investment securities were classified as long
        term assets on the balance sheet.



    Consolidated Results - Highlights

    Revenues - Constant Currency

    ($ In Millions)      Q2 2009  Y/Y Foreign  Q2 2009    Q2 2008  Adj/Actual
                         Actual     Exchange  Adjusted    Actual     % Change
                         ------     --------  --------    ------     --------

      Acute Care          $188.6         $4.3   $192.9    $230.9       -16.5%
      Post Acute Care       48.9            -     48.9      48.0         1.9%
      International and
       Surgical            100.8         12.2    113.0      97.0        16.5%
      Eliminations          (1.0)           -     (1.0)     (0.7)       42.9%
                            ----        -----     ----      ----        ----
    Total                 $337.3        $16.5   $353.8    $375.2        -5.7%
                          ======        =====   ======    ======        ====


                        YTD 2009  Y/Y Foreign YTD 2009  YTD 2008   Adj/Actual
                         Actual     Exchange  Adjusted   Actual      % Change
                         ------     --------  --------    ------     --------

      Acute Care          $392.1         $6.4   $398.5    $442.2        -9.9%
      Post Acute Care       99.3            -     99.3      96.1         3.3%
      International and
       Surgical            199.7         20.2    219.9     180.5        21.8%
      Eliminations          (2.2)           -     (2.2)     (2.2)        0.0%
                            ----        -----     ----      ----         ---
    Total                 $688.9        $26.6   $715.5    $716.6        -0.2%
                          ======        =====   ======    ======        ====


    Non-GAAP Financial Disclosures and Reconciliations

    While Hill-Rom reports financial results in accordance with U.S. GAAP,
    this press release includes non-GAAP measures. These non-GAAP measures are
    not in accordance with, nor are they a substitute for, GAAP measures.
    Hill-Rom uses the non-GAAP measures to evaluate and manage its operations
    and provides the information to assist investors in performing financial
    analysis that is consistent with financial models developed by research
    analysts. Investors should consider non-GAAP measures in addition to, not
    as a substitute for, or as superior to, measures of financial performance
    prepared in accordance with GAAP.


                                                          Income from
                             Loss from Continuing    Continuing Operations
    Second Quarter             Operations - 2009             - 2008
                             --------------------   ----------------------
                                    Income Diluted          Income  Diluted
                           Pre-tax   Taxes   EPS    Pre-tax  Taxes    EPS
                           -------   -----   ---    -------  -----    ---

    (Loss) Income from
     continuing
     operations - GAAP     $(464.0)   $1.8  $(7.44)   $16.9   $7.5   $0.15
    Adjustments:
      Impairment of
       goodwill and
       other intangibles     470.0       -    7.51        -      -       -
      Effect of Liko
       inventory valuation     1.0     0.3    0.01        -      -       -
      Acquisition
       integration charges     0.8     0.3    0.01        -      -       -
      Special charges         17.8     6.6    0.18        -      -       -
      Stock modification
       charge                    -       -       -      5.8    2.1    0.06
      Loss on
       extinguishment of
       debt                      -       -       -      3.2    1.2    0.03
      Separation costs           -       -       -      1.5    0.4    0.02
                               ---     ---     ---      ---    ---    ----

    Income from continuing
     operations - Adjusted   $25.6    $9.0   $0.27    $27.4  $11.2   $0.26
                             =====    ====   =====    =====  =====   =====


                                                          Income from
                             Loss from Continuing    Continuing Operations
    Year-to-Date               Operations - 2009             - 2008
                             --------------------   ----------------------
                                    Income Diluted          Income  Diluted
                           Pre-tax   Taxes   EPS    Pre-tax  Taxes    EPS
                           -------   -----   ---    -------  -----    ---

    (Loss) Income from
     continuing
     operations - GAAP     $(443.0)   $8.6  $(7.22)   $37.5  $15.7   $0.35
    Adjustments:
      Impairment of
       goodwill and
       other intangibles     470.0       -    7.51        -      -       -
      Effect of Liko
       inventory valuation     2.9     0.8    0.03        -      -       -
      Acquisition
       integration charges     1.1     0.4    0.01        -      -       -
      Special charges         17.8     6.6    0.18      2.3    0.9    0.02
      Stock modification
       charge                    -       -       -      5.8    2.1    0.06
      Loss on
       extinguishment of
       debt                      -       -       -      3.2    1.2    0.03
      Separation costs           -       -       -      1.6    0.4    0.02
                               ---     ---     ---      ---    ---    ----

    Income from continuing
     operations - Adjusted   $48.8   $16.4   $0.52    $50.4  $20.3   $0.48
                             =====   =====   =====    =====  =====   =====


    Note:  Certain per share amounts may not accurately add due to rounding.

    Note:  Earnings in the above presentation of adjusted income from
    continuing operations have not been adjusted to remove the effects of
    discrete period tax adjustments recognized in any of the periods
    presented.  Discrete period tax adjustments are routinely recognized
    throughout any given year under a variety of circumstances and are highly
    subjective in nature.  For the three- and six-month periods ended March
    31, 2009, we recognized discrete tax expense of $0.8 million and discrete
    tax benefits of $0.5 million, respectively, compared to discrete tax
    expense of $1.8 million and $1.1 million in the prior period comparable
    periods.

    Selected Summary Balance Sheet Schedule

                                                       3/31/2009  12/31/2008
                                                       ---------  ----------
    Assets
    Current Assets
      Cash and cash equivalents                           $84.6      $49.5
      Trade accounts receivable, net of allowances        326.3      348.8
      Inventories                                         120.3      127.3
      Other current assets                                 66.7       50.1
                                                           ----       ----
        Total current assets                              597.9      575.7

    Equipment leased to others, net                       163.3      164.3
    Property, net                                         119.5      124.9
    Goodwill                                               80.9      539.1
    Other assets                                          210.1      221.4
                                                          -----      -----

      Total Assets                                     $1,171.7   $1,625.4
                                                       ========   ========

    Liabilities
    Current Liabilities
      Trade accounts payable                              $72.4      $80.7
      Short-term borrowings                               125.9      122.0
      Other current liabilities                           157.3      144.3
                                                          -----      -----
        Total current liabilities                         355.6      347.0

    Long-term debt                                         99.5      100.8
    Other long-term liabilities                           136.6      115.4
                                                          -----      -----

      Total Liabilities                                   591.7      563.2
                                                          -----      -----

    Shareholders' Equity                                  580.0    1,062.2
                                                          -----    -------

    Total Liabilities and
     Shareholders' Equity                              $1,171.7   $1,625.4
                                                       ========   ========



    Financial Guidance for Fiscal Year 2009

                                                     Actual    2009 Range
       ($ in millions, except EPS)                    2008    Low    High
                                                      ----   -----  ------

      Net Revenues
          Capital sales                            $1,044    $895    $946
          Rental revenues                             464     470     477
                                                      ---     ---     ---
      Total revenues                                1,508   1,365   1,423
            YoY % Change                             11.1%   -9.5%   -5.6%

          Capital sales gross margin %               40.7%   39.0%   40.0%
          Rental revenues gross margin %             52.6%   54.3%   55.0%
          Total gross margin %                       44.4%   44.2%   45.1%

      Other operating expenses                        544     518     527
      Special charges and other
       items (see below)                               23     492     492

      Operating Profit (Loss)                         103    (406)   (377)
      Other income / (expense)                        (11)     (8)     (8)
                                                      ---      --      --
      Income (Loss) from Continuing Operations
       before Income Taxes                             92    (414)   (385)



      Income (Loss) from Continuing
       Operations - GAAP (1)                          $67   $(433)  $(414)
      Impairment of goodwill and other
       intangibles (2)                                  -     470     470
      Liko acquisition inventory step-up                -       2       2
      Liko acquisition integration charges              -       1       1
      Special charges (3)                              14      13      13
      Stock modification charge                         4       -       -
      Loss on extinguishment of debt                    2       -       -
      Separation costs                                  1       -       -
                                                      ---     ---     ---

      Income from Continuing Operations -
        Adjusted (4)                                  $88     $53     $72
                                                      ===     ===     ===


      Earnings (Loss) per share - GAAP (1)          $1.07  $(6.91) $(6.61)
      Impairment of goodwill and other
       intangibles (2)                                  -    7.51    7.51
      Liko acquisition inventory step-up                -    0.03    0.03
      Liko acquisition integration charges              -    0.02    0.02
      Special charges (3)                            0.22    0.20    0.20
      Stock modification charge                      0.06       -       -
      Loss on extinguishment of debt                 0.03       -       -
      Separation costs                               0.02       -       -
                                                     ----     ---     ---


      Earnings per share - Adjusted (4)             $1.40   $0.85   $1.15
                                                    =====   =====   =====



    (1) Effective tax rate for last half of fiscal 2009 estimated to be in
        range of 32 to 34 percent, excluding any future discrete tax items.

    (2) Does not reflect any true-up of estimated impairment charge in Q3 as
        amount of any such adjustment is unknown at this time.

    (3) Special charges in fiscal 2009 includes year-to-date charge of $17.8
        million and an estimated additional charge of $2 million related to
        the finalization of the actions previously announced in January.

    (4) Adjusted earnings in the above presentation have not been adjusted
        to remove the effects of discrete period tax adjustments recognized in
        any of the periods presented. Discrete period tax adjustments are
        routinely recognized throughout any given year under a variety of
        circumstances and are highly subjective in nature. For fiscal year
        2008, discrete tax benefits totaled $8.3 million ($0.13 per share),
        while year-to-date discrete tax benefits in fiscal 2009 totaled $0.5
        million ($0.01 per share).


'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Hill-Rom to Present at the Bank of America 2009 Health Care Conference
2. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
3. JCR and Hill-Rom Name First Nurse Scholar-in-Residence
4. Hill-Rom Announces Second Quarter 2009 Dividend
5. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
6. Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
7. DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
9. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
10. JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
11. Hill-Rom Announces First Quarter 2009 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and ... J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA ... Southern Nevada Healthcare System. This will be the first Fisher House in Nevada, ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization that ... partnership with San Ramon Regional Medical Center. Under the collaboration, the first of its ... to accommodate a more certain time frame for donor families for the recovery of ...
(Date:2/12/2016)... Land, TX (PRWEB) , ... February 12, 2016 ... ... families of southwest Houston and surrounding communities by continuing it’s commitment to act ... Bend Family Promise. The organization works closely with area homeless families to fulfill ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. 24 ... maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
(Date:2/11/2016)... 2016 Laboratory glassware and plasticware ... These may range from microscope slides to large storage ... from borosilicate glass because of its low weight and ... hand, started gaining popularity over the past decade when ... glass with plastic in several applications due to its ...
(Date:2/11/2016)... 11, 2016   Health 2.0 , the premiere ... technologies, announced today " 10 Year Global Retrospective ", ... over the past ten years.   ... Health 2.0 has served as the preeminent thought-leader in ... thousands of technologies, companies, innovators, and patient-activists through an ...
Breaking Medicine Technology: